April 3, 2017
TOKYO, JAPAN - April 3, 2017 - Terumo Corporation (TSE: 4543) today announced that it completed its acquisition of Bolton Medical, Inc. for US$ 174 million on March 31, 2017 (North American Eastern Standard Time). Bolton Medical is a leading innovator in thoracic and abdominal stent graft systems.
Bolton Medical has become a part of Terumo's Vascular Graft Division within the Cardiac and Vascular Company. The acquisition will enhance Terumo's existing product portfolio in the global stent graft market and our vascular graft business will be further strengthened in the US, in what is the largest stent graft market today.
The impact of the acquisition on Terumo's business performance is being examined. Further details regarding the impact will be disclosed, as needed, once the analysis is completed.
Bolton Medical is a leading provider of endovascular solutions for aortic disease based in Sunrise, Florida, US, with 45 million Euros in sales and over 300 employees; committed to improving quality and safety in patient care by developing, manufacturing and distributing innovative, high quality products and technology solely focused on the aorta to include TAA, AAA and custom made stent graft systems.
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 countries. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.
Vascular Graft Division is a division of the Cardiac and Vascular Company, Terumo Corporation. Vascutek Ltd, which became a part of Terumo in 2002, leads this division and has applied advanced and innovative technologies to develop a wide portfolio of products which include an extensive range of sealed woven and knitted polyester grafts for peripheral, abdominal and cardiothoracic surgery. Net sales are 13.9 billion yen (FY2015).
(Notice) Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.